Clinical Trials Sponsored by Paul Larson

Total 4449 results

Lawson Health Research Institute

Completed

Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array

Healthy | Estrogen Replacement Therapy

Canada
Lawson Health Research Institute

Completed

Comparison of GlideScope Specific Stylet to Malleable Stylet for GlideScope Intubation

Intubation, Endotracheal

Canada
Lawson Health Research Institute

Terminated

Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors

Bladder Cancer

Canada
Lawson Health Research Institute

Terminated

Randomized Trial Comparing N of 1 Trials to Standard Practice to Improve Adherence to Statins in Patients With Diabetes

Cardiovascular Disease | Diabetes | Hyperlipidemia

Canada
Paul Bollyky

Completed

A Study of Oral Hymecromone and Hyaluronan Synthesis

Healthy | Respiratory Disease

United States
Institut Curie
Paul Hartmann

Completed

Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial (HYDROSORB)

Breast Cancer | Radiation Dermatitis

France
Concordia University, St. Paul

Completed

The Effects of Guarding on the Outcomes of the Six Minute Walk Test

Physical Activity | Rehabilitation | Functional Capacity

United States
Clarkson University

Recruiting

The Effect of Auditory Cues on Mood and Gait

Psychological | Auditory Perception

United States
Parion Sciences

Terminated

Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease

Dry Eye Disease

United States
Barwon Health

Terminated

A Pilot Study to Assess the Follow-up of Prostate Cancer Patients Who Have Undergone Radiotherapy Treatment (PROFUGO)

Prostate Cancer

Australia
Samson NeuroSciences

Unknown

Safety Study of Carotid Body Neurostimulation to Treat Cerebral Vasospasm

Aneurysmal Subarachnoid Hemorrhage | Cerebral Vasospasm

Germany, Czech Republic, Israel
Watson Pharmaceuticals

Completed

Study of Silodosin to Facilitate Passage of Urinary Stones

Urolithiasis | Ureteral Calculi | Kidney Stones

United States
Watson Pharmaceuticals

Completed

Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

Prostate Cancer

United States
Watson Pharmaceuticals

Completed

Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome

Interstitial Cystitis | Painful Bladder Syndrome

United States
Watson Pharmaceuticals

Withdrawn

Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma

Leiomyomas

United States
Watson Pharmaceuticals

Completed

Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems

Hypogonadism

United States
Watson Pharmaceuticals

Completed

Effect of Two Iron Preparations on Protein in the Urine

Anemia, Iron-Deficiency | Kidney Failure, Chronic

United States
Watson Pharmaceuticals

Completed

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients

Anemia, Iron-Deficiency | Kidney Failure, Chronic

United States, Puerto Rico
Watson Pharmaceuticals

Completed

Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.

Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome

United States
Watson Pharmaceuticals

Completed

A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition

Detrusor Hyperreflexia

United States
Paul Carlson
University of Utah; Western Institute for Biomedical Research; Molecular Imaging...

Terminated

Use of Multiple Brain Imaging Modalities (PET and MRS) to Identify Metabolic Abnormalities in Major Depression

Major Depressive Disorder

United States
Lawson Health Research Institute
Sanofi

Completed

Advancing Insulin Prescribing in General Practice (AIM@GP)

Diabetes Mellitus

Canada
Maria Larsson

Completed

Medical Yoga for Patients With Stress-related Symptoms

Stress-related Illness/Anxiety

Sweden
Lawson Health Research Institute
Pfizer

Completed

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

Embolism and Thrombosis

Canada
Lawson Health Research Institute
Pfizer

Completed

Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema) (PEGAP001)

Diabetic Macular Edema | Proliferative Diabetic Retinopathy

Canada
Lawson Health Research Institute
Medtronic

Completed

Effectiveness of Pulmonary Vein Isolation in Prevention of Atrial Fibrillation Following Heart Bypass Surgery

Atrial Fibrillation

Canada
Parion Sciences

Completed

An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness

Sjogren's Syndrome | Xerostomia

United States
Parion Sciences

Terminated

Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease

Dry Eye Disease

United States
Watson Pharmaceuticals

Completed

Safety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary Hyperhidrosis

Hyperhidrosis

United States
Parion Sciences

Completed

Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease

Dry Eye Disease

United States
Watson Pharmaceuticals

Completed

2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.

Iron Deficiency Anemia

United States, Canada, Mexico, Bulgaria, India, Russian Federation, Croatia, Poland
Watson Pharmaceuticals

Completed

Effects of Oxybutynin Topical Gel on Gastric Emptying

Healthy

United States
Watson Pharmaceuticals

Completed

Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men

Hypogonadism

United States
Watson Pharmaceuticals

Completed

Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients

Anemia

United States, Poland, Mexico, Serbia, Russian Federation
Watson Pharmaceuticals

Completed

A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia

Prostatic Hyperplasia | Nocturia

United States
Watson Pharmaceuticals

Completed

Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy

Anemia

United States
Watson Pharmaceuticals

Completed

Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition

Detrusor Hyperreflexia

United States
Watson Pharmaceuticals

Completed

Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder (MATRIX)

Quality of Life | Overactive Bladder | Urinary Incontinence

United States
Watson Pharmaceuticals

Completed

A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

Benign Prostatic Hyperplasia (BPH)

United States
Watson Pharmaceuticals

Completed

A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo

Overactive Bladder

United States
Watson Pharmaceuticals

Completed

The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months

Benign Prostatic Hyperplasia

United States
Watson Pharmaceuticals

Completed

A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

Benign Prostatic Hyperplasia

United States
Parion Sciences

Completed

Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients

Cystic Fibrosis

United States
Clarkson University

Recruiting

Concurrent Vestibular Activation and Postural Training Using Virtual Reality (VR-HS-WST)

Vestibular Disorder

United States
Parion Sciences

Completed

A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome

Xerostomia | Dry Mouth Associated With Sjogren's Syndrome

United States
Barwon Health

Unknown

IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer (Neonab)

Breast Cancer

Australia
Watson Pharmaceuticals

Completed

DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin) (DRIVE)

Anemia, Iron-Deficiency | Hemodialysis | Kidney Failure, Chronic

United States
Watson Pharmaceuticals

Completed

Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception (Simplify)

Contraceptive Usage

United States
Watson Pharmaceuticals

Completed

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents

Anemia, Iron-Deficiency | Kidney Failure, Chronic

United States, Puerto Rico
Watson Pharmaceuticals

Completed

Comparison Between Effects of Two Iron Preparations on Protein in the Urine

Anemia, Iron-Deficiency | Kidney Failure, Chronic

United States, Puerto Rico

3

Subscribe